Literature DB >> 6089901

Modulation of lipoprotein lipase in the intact rat by cholera toxin--an irreversible agonist of cyclic AMP.

H Knobler, T Chajek-Shaul, O Stein, J Etienne, Y Stein.   

Abstract

Rats were injected intravenously with cholera toxin, a potent stimulator of adenylate cyclase, and lipoprotein lipase was determined in various organs and plasma. 16 h after cholera toxin injection, lipoprotein lipase activity increased 2-6-fold in heart, diaphragm and lung and decreased to one-third in adipose tissue. An increase in lipoprotein lipase activity was seen in the plasma and in the liver, as determined by antiserum to lipoprotein lipase. The increase in heart lipoprotein lipase was preceded by a rise in cyclic AMP and continued for 24 h when cyclic AMP returned to base-line levels. Both heparin-releasable and residual lipoprotein lipase increased in the heart, but to an unequal extent. The more pronounced rise in residual activity (up to 10-fold) could have contributed to an increase in the t1/2 of heart lipoprotein lipase from 1.5 to 2.6 h. The relatively lower increase in heparin-releasable lipoprotein lipase could have been due to a loss of the enzyme from this compartment into the circulation. The effect of cholera toxin on heart and adipose tissue lipoprotien lipase was observed in fasted, fed and super-fed animals and thus appears to be independent of the nutritional state of the animal. Since cholera toxin not only mimics hormonal stimulation, but causes an exaggerated response to hormones, it made studies on some aspects of regulation of both the functional and storage forms of lipoprotein lipase in the intact organism possible.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089901     DOI: 10.1016/0005-2760(84)90087-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity.

Authors:  D L Severson; R Carroll; A Kryski; I Ramírez
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  Lipoprotein lipase activity in neonatal-rat liver cell types.

Authors:  F Burgaya; J Peinado; S Vilaró; M Llobera; I Ramírez
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.

Authors:  R Carroll; A Juhasz; D L Severson
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

4.  Intralipid administration induces a lipoprotein lipase-like activity in the livers of starved adult rats.

Authors:  S Vilaró; M Reina; I Ramírez; M Llobera
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

5.  Synthesis of lipoprotein lipase in the liver of newborn rats and localization of the enzyme by immunofluorescence.

Authors:  S Vilaró; M Llobera; G Bengtsson-Olivecrona; T Olivecrona
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

6.  Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia.

Authors:  K J Williams; K A Petrie; R W Brocia; T L Swenson
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.